FM
RDHL

Family Management’s Redhill Biopharma RDHL Stock Holding History

Family Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38
Closed -$408K – 68
2017
Q3 		$408K Buy
38
+12
+46% +$107K 0.28% 45
2017
Q2 		$222K Buy
26
+9
+53% +$86.5K 0.15% 52
2017
Q1 		$163K Buy
+17
New +$170K 0.11% 58
2016
Q4 		– Sell
-17
Closed -$229K – 77
2016
Q3 		$229K Hold
17
– – 0.13% 68
2016
Q2 		$179K Hold
17
– – 0.1% 74
2016
Q1 		$202K Buy
17
+2
+13% +$20.9K 0.13% 64
2015
Q4 		$187K Sell
15
-7
-32% -$87.1K 0.1% 71
2015
Q3 		$284K Buy
+22
New +$326K 0.13% 76

Other funds holding RDHL

6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $146M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.43B AUM 44.68% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return